2024 annual financial data
Mirum Pharmaceuticals 2024 Operating margin
Mirum Pharmaceuticals 2024 operating margin with verified reported values.
Direct answer
Operating margin was -26%.
Operating income was -87,606,000 USD and net income was -87,942,000 USD.
Operating cash flow was 10,325,000 USD.
Get free Mirum Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 336,888,000 USD
- Operating income
- -87,606,000 USD
- Net income
- -87,942,000 USD
- Operating cash flow
- 10,325,000 USD